Biovica International AB (OSTO:BIOVIC B) Net Change in Cash : kr-39.91 Mil (TTM As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Biovica International AB Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Biovica International AB's Net Change in Cash for the three months ended in Jan. 2024 was kr58.31 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 was kr-39.91 Mil.

Biovica International AB Net Change in Cash Historical Data

The historical data trend for Biovica International AB's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biovica International AB Net Change in Cash Chart

Biovica International AB Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Net Change in Cash

Get a 7-Day Free Trial

-25.30

23.95

104.59

-55.57

24.54

Biovica International AB Quarterly Data
	Apr19	Jul19	Oct19	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Net Change in Cash	Get a 7-Day Free Trial															98.15	-30.82	-38.63	-28.77	58.31

Biovica International AB Net Change in Cash Calculation

Biovica International AB's Net Change in Cash for the fiscal year that ended in Apr. 2023 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	-94.64	+	-2.779	+	122.009	+	-0.054
	=	24.54

Biovica International AB's Net Change in Cash for the quarter that ended in Jan. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= -22.76 + 0.016 + 81.857 + -0.806

= 58.31

Net Change in Cash for the trailing twelve months (TTM) ended in Jan. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-39.91 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biovica International AB Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Biovica International AB's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Biovica International AB (OSTO:BIOVIC B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biovica International AB (OSTO:BIOVIC B) » Definitions » Net Change in Cash

Comparable Companies

OSTO:ISOFOL OSTO:SPRINT OSTO:ELIC OSTO:ALZ OSTO:NXTCL XSAT:CESSA OSTO:ACE OSTO:LIPUM OSTO:SIMRIS B OSTO:ZICC OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX

Traded in Other Exchanges

9II:Germany

Address

Dag Hammarskjolds vag 54B, Uppsala Science Park, Uppsala, SWE, 752 37

Website

http://www.biovica.com

Biovica International AB is a biotech company. It develops and commercializes blood-based diagnostic tests with biomarkers that improve monitoring and evaluation of modern cancer treatments. Through collaboration with world- leading cancer institutes and pharmaceutical companies, it promotes the trend in healthcare for personalized treatment, with a primary focus on patient survival and benefits to society. DiviTum is manufactured by the company and sold as a kit consisting of a reaction plate with reagents that have been optimized for ELISA applications.

Biovica International AB (OSTO:BIOVIC B) Headlines

No Headlines